Review



wild type c57bl6 j mice  (Inotiv)


Bioz Verified Symbol Inotiv is a verified supplier
Bioz Manufacturer Symbol Inotiv manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 99
      Buy from Supplier

    Structured Review

    Inotiv wild type c57bl6 j mice
    VGluT2 + SUB→RSP afferents are specifically required for processing a temporal trace separating a cue and a shock (A, D, and G) Experimental design of behavioral tasks. Diagrams depict virus infusion sites in DH and cannula placements for CNO injections in RSP (top and right), and viral expression in RSP and DH (bottom and right). (B) When compared to vehicle, CNO injections 30 min before TFC training, impaired freezing at test in response to both the tone and trace periods in mice receiving AAV-hM4D (Gi) ( n = 9–10; two-way ANOVA with repeated measures; factor: treatment, p = 0.0098, F (1, 17) = 8.444, factor: phase, p < 0.0001, F (2, 34) = 67.41, factor: trial × phase, p = 0.0084, F (2, 34) = 5.522). (C) CNO injection before training in delay fear conditioning (DFC) did not affect freezing to tone or post-tone when compared to vehicle-injected mice ( n = 9–10; two-way ANOVA with repeated measures; factor: treatment, p = 0.6738, F (1, 17) = 0.1835, factor: phase, p < 0.0001, F (2, 34) = 97.84, factor: trial × phase, p = 0.1764, F (2, 34) = 1.827). (E) In VGluT2-Cre mice, CNO injection 30 min before training significantly impaired freezing during the trace but not tone compared to vehicle group ( n = 10; two-way ANOVA with repeated measures; factor: treatment, p = 0.0132, F (1, 18) = 7.565, factor: phase, p < 0.0001, F (2, 36) = 41.47, factor: trial × phase, p = 0.0001, F (2, 36) = 12.00. (F) In VGluT1-Cre mice, terminal silencing with CNO did not affect freezing compared to vehicle controls ( n = 9; two-way ANOVA with repeated measures; factor: treatment, p = 0.0931, F (1, 16) = 3.189, factor: phase, p < 0.0001, F (2, 32) = 13.78, factor: trial × phase, p = 0.9968, F (2, 32) = 0.003253) when compared to vehicle controls. (H) Injections of CNO ( n = 10) before trace-light conditioning (TLC) training did not affect freezing during either the tone or light periods in mice expressing inhibitory DREADD only in VGluT2 + SUB→RSP projections ( n = 10; two-way ANOVA with repeated measures; factor: treatment, p = 0.2577, F (1, 18) = 1.366, factor: phase, p < 0.0001, F (2, 36) = 52.27, factor: trial × phase, p = 0.5714, F (2, 36) = 0.5685). (I) Injections of CNO before TLC training significantly impaired freezing to both tone and light when compared to vehicle in mice expressing inhibitory DREADD in all SUB→RSP projections compared to vehicle injected group ( n = 5–6; two-way ANOVA with repeated measures; factor: treatment, p = 0.0087, F (1, 9) = 11.12, factor: phase, p < 0.0001, F (2, 18) = 19.01, factor: trial × phase, p = 0.3846, F (2, 18) = 1.008. Data presented as mean ± SEM ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001; NS, not significant; WT, <t>wild-type.</t> All scale bars, 250 μm.
    Wild Type C57bl6 J Mice, supplied by Inotiv, used in various techniques. Bioz Stars score: 99/100, based on 15254 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/wild+type+c57bl6+j+mice/pmc13068534-239-0-7?v=Inotiv
    Average 99 stars, based on 15254 article reviews
    wild type c57bl6 j mice - by Bioz Stars, 2026-08
    99/100 stars

    Images

    1) Product Images from "Response dynamics of discrete subiculum→retrosplenial cortex projections underlying trace fear conditioning"

    Article Title: Response dynamics of discrete subiculum→retrosplenial cortex projections underlying trace fear conditioning

    Journal: iScience

    doi: 10.1016/j.isci.2026.115317

    VGluT2 + SUB→RSP afferents are specifically required for processing a temporal trace separating a cue and a shock (A, D, and G) Experimental design of behavioral tasks. Diagrams depict virus infusion sites in DH and cannula placements for CNO injections in RSP (top and right), and viral expression in RSP and DH (bottom and right). (B) When compared to vehicle, CNO injections 30 min before TFC training, impaired freezing at test in response to both the tone and trace periods in mice receiving AAV-hM4D (Gi) ( n = 9–10; two-way ANOVA with repeated measures; factor: treatment, p = 0.0098, F (1, 17) = 8.444, factor: phase, p < 0.0001, F (2, 34) = 67.41, factor: trial × phase, p = 0.0084, F (2, 34) = 5.522). (C) CNO injection before training in delay fear conditioning (DFC) did not affect freezing to tone or post-tone when compared to vehicle-injected mice ( n = 9–10; two-way ANOVA with repeated measures; factor: treatment, p = 0.6738, F (1, 17) = 0.1835, factor: phase, p < 0.0001, F (2, 34) = 97.84, factor: trial × phase, p = 0.1764, F (2, 34) = 1.827). (E) In VGluT2-Cre mice, CNO injection 30 min before training significantly impaired freezing during the trace but not tone compared to vehicle group ( n = 10; two-way ANOVA with repeated measures; factor: treatment, p = 0.0132, F (1, 18) = 7.565, factor: phase, p < 0.0001, F (2, 36) = 41.47, factor: trial × phase, p = 0.0001, F (2, 36) = 12.00. (F) In VGluT1-Cre mice, terminal silencing with CNO did not affect freezing compared to vehicle controls ( n = 9; two-way ANOVA with repeated measures; factor: treatment, p = 0.0931, F (1, 16) = 3.189, factor: phase, p < 0.0001, F (2, 32) = 13.78, factor: trial × phase, p = 0.9968, F (2, 32) = 0.003253) when compared to vehicle controls. (H) Injections of CNO ( n = 10) before trace-light conditioning (TLC) training did not affect freezing during either the tone or light periods in mice expressing inhibitory DREADD only in VGluT2 + SUB→RSP projections ( n = 10; two-way ANOVA with repeated measures; factor: treatment, p = 0.2577, F (1, 18) = 1.366, factor: phase, p < 0.0001, F (2, 36) = 52.27, factor: trial × phase, p = 0.5714, F (2, 36) = 0.5685). (I) Injections of CNO before TLC training significantly impaired freezing to both tone and light when compared to vehicle in mice expressing inhibitory DREADD in all SUB→RSP projections compared to vehicle injected group ( n = 5–6; two-way ANOVA with repeated measures; factor: treatment, p = 0.0087, F (1, 9) = 11.12, factor: phase, p < 0.0001, F (2, 18) = 19.01, factor: trial × phase, p = 0.3846, F (2, 18) = 1.008. Data presented as mean ± SEM ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001; NS, not significant; WT, wild-type. All scale bars, 250 μm.
    Figure Legend Snippet: VGluT2 + SUB→RSP afferents are specifically required for processing a temporal trace separating a cue and a shock (A, D, and G) Experimental design of behavioral tasks. Diagrams depict virus infusion sites in DH and cannula placements for CNO injections in RSP (top and right), and viral expression in RSP and DH (bottom and right). (B) When compared to vehicle, CNO injections 30 min before TFC training, impaired freezing at test in response to both the tone and trace periods in mice receiving AAV-hM4D (Gi) ( n = 9–10; two-way ANOVA with repeated measures; factor: treatment, p = 0.0098, F (1, 17) = 8.444, factor: phase, p < 0.0001, F (2, 34) = 67.41, factor: trial × phase, p = 0.0084, F (2, 34) = 5.522). (C) CNO injection before training in delay fear conditioning (DFC) did not affect freezing to tone or post-tone when compared to vehicle-injected mice ( n = 9–10; two-way ANOVA with repeated measures; factor: treatment, p = 0.6738, F (1, 17) = 0.1835, factor: phase, p < 0.0001, F (2, 34) = 97.84, factor: trial × phase, p = 0.1764, F (2, 34) = 1.827). (E) In VGluT2-Cre mice, CNO injection 30 min before training significantly impaired freezing during the trace but not tone compared to vehicle group ( n = 10; two-way ANOVA with repeated measures; factor: treatment, p = 0.0132, F (1, 18) = 7.565, factor: phase, p < 0.0001, F (2, 36) = 41.47, factor: trial × phase, p = 0.0001, F (2, 36) = 12.00. (F) In VGluT1-Cre mice, terminal silencing with CNO did not affect freezing compared to vehicle controls ( n = 9; two-way ANOVA with repeated measures; factor: treatment, p = 0.0931, F (1, 16) = 3.189, factor: phase, p < 0.0001, F (2, 32) = 13.78, factor: trial × phase, p = 0.9968, F (2, 32) = 0.003253) when compared to vehicle controls. (H) Injections of CNO ( n = 10) before trace-light conditioning (TLC) training did not affect freezing during either the tone or light periods in mice expressing inhibitory DREADD only in VGluT2 + SUB→RSP projections ( n = 10; two-way ANOVA with repeated measures; factor: treatment, p = 0.2577, F (1, 18) = 1.366, factor: phase, p < 0.0001, F (2, 36) = 52.27, factor: trial × phase, p = 0.5714, F (2, 36) = 0.5685). (I) Injections of CNO before TLC training significantly impaired freezing to both tone and light when compared to vehicle in mice expressing inhibitory DREADD in all SUB→RSP projections compared to vehicle injected group ( n = 5–6; two-way ANOVA with repeated measures; factor: treatment, p = 0.0087, F (1, 9) = 11.12, factor: phase, p < 0.0001, F (2, 18) = 19.01, factor: trial × phase, p = 0.3846, F (2, 18) = 1.008. Data presented as mean ± SEM ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001; NS, not significant; WT, wild-type. All scale bars, 250 μm.

    Techniques Used: Virus, Expressing, Injection



    Similar Products

    wild type c57bl6 j mice  (Jackson Laboratory)
    86
    Jackson Laboratory wild type c57bl6 j mice
    Wild Type C57bl6 J Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/wild+type+c57bl6+j+mice/pm42162419-492-0-6?v=Jackson+Laboratory
    Average 86 stars, based on 1 article reviews
    wild type c57bl6 j mice - by Bioz Stars, 2026-08
    86/100 stars
    		  Buy from Supplier
    mouse lines c57bl6 j wild type mice  (Jackson Laboratory)
    86
    Jackson Laboratory mouse lines c57bl6 j wild type mice
    Mouse Lines C57bl6 J Wild Type Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/wild+type+c57bl6+j+mice/us12624362-1053-1-10?v=Jackson+Laboratory
    Average 86 stars, based on 1 article reviews
    mouse lines c57bl6 j wild type mice - by Bioz Stars, 2026-08
    86/100 stars
    		  Buy from Supplier
    wild type c57bl6 j mice  (Inotiv)
    99
    Inotiv wild type c57bl6 j mice
    VGluT2 + SUB→RSP afferents are specifically required for processing a temporal trace separating a cue and a shock (A, D, and G) Experimental design of behavioral tasks. Diagrams depict virus infusion sites in DH and cannula placements for CNO injections in RSP (top and right), and viral expression in RSP and DH (bottom and right). (B) When compared to vehicle, CNO injections 30 min before TFC training, impaired freezing at test in response to both the tone and trace periods in mice receiving AAV-hM4D (Gi) ( n = 9–10; two-way ANOVA with repeated measures; factor: treatment, p = 0.0098, F (1, 17) = 8.444, factor: phase, p < 0.0001, F (2, 34) = 67.41, factor: trial × phase, p = 0.0084, F (2, 34) = 5.522). (C) CNO injection before training in delay fear conditioning (DFC) did not affect freezing to tone or post-tone when compared to vehicle-injected mice ( n = 9–10; two-way ANOVA with repeated measures; factor: treatment, p = 0.6738, F (1, 17) = 0.1835, factor: phase, p < 0.0001, F (2, 34) = 97.84, factor: trial × phase, p = 0.1764, F (2, 34) = 1.827). (E) In VGluT2-Cre mice, CNO injection 30 min before training significantly impaired freezing during the trace but not tone compared to vehicle group ( n = 10; two-way ANOVA with repeated measures; factor: treatment, p = 0.0132, F (1, 18) = 7.565, factor: phase, p < 0.0001, F (2, 36) = 41.47, factor: trial × phase, p = 0.0001, F (2, 36) = 12.00. (F) In VGluT1-Cre mice, terminal silencing with CNO did not affect freezing compared to vehicle controls ( n = 9; two-way ANOVA with repeated measures; factor: treatment, p = 0.0931, F (1, 16) = 3.189, factor: phase, p < 0.0001, F (2, 32) = 13.78, factor: trial × phase, p = 0.9968, F (2, 32) = 0.003253) when compared to vehicle controls. (H) Injections of CNO ( n = 10) before trace-light conditioning (TLC) training did not affect freezing during either the tone or light periods in mice expressing inhibitory DREADD only in VGluT2 + SUB→RSP projections ( n = 10; two-way ANOVA with repeated measures; factor: treatment, p = 0.2577, F (1, 18) = 1.366, factor: phase, p < 0.0001, F (2, 36) = 52.27, factor: trial × phase, p = 0.5714, F (2, 36) = 0.5685). (I) Injections of CNO before TLC training significantly impaired freezing to both tone and light when compared to vehicle in mice expressing inhibitory DREADD in all SUB→RSP projections compared to vehicle injected group ( n = 5–6; two-way ANOVA with repeated measures; factor: treatment, p = 0.0087, F (1, 9) = 11.12, factor: phase, p < 0.0001, F (2, 18) = 19.01, factor: trial × phase, p = 0.3846, F (2, 18) = 1.008. Data presented as mean ± SEM ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001; NS, not significant; WT, <t>wild-type.</t> All scale bars, 250 μm.
    Wild Type C57bl6 J Mice, supplied by Inotiv, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/wild+type+c57bl6+j+mice/pmc13068534-239-0-7?v=Inotiv
    Average 99 stars, based on 1 article reviews
    wild type c57bl6 j mice - by Bioz Stars, 2026-08
    99/100 stars
    		  Buy from Supplier
    wild type c57bl6 j mice  (Charles River Laboratories)
    86
    Charles River Laboratories wild type c57bl6 j mice
    VGluT2 + SUB→RSP afferents are specifically required for processing a temporal trace separating a cue and a shock (A, D, and G) Experimental design of behavioral tasks. Diagrams depict virus infusion sites in DH and cannula placements for CNO injections in RSP (top and right), and viral expression in RSP and DH (bottom and right). (B) When compared to vehicle, CNO injections 30 min before TFC training, impaired freezing at test in response to both the tone and trace periods in mice receiving AAV-hM4D (Gi) ( n = 9–10; two-way ANOVA with repeated measures; factor: treatment, p = 0.0098, F (1, 17) = 8.444, factor: phase, p < 0.0001, F (2, 34) = 67.41, factor: trial × phase, p = 0.0084, F (2, 34) = 5.522). (C) CNO injection before training in delay fear conditioning (DFC) did not affect freezing to tone or post-tone when compared to vehicle-injected mice ( n = 9–10; two-way ANOVA with repeated measures; factor: treatment, p = 0.6738, F (1, 17) = 0.1835, factor: phase, p < 0.0001, F (2, 34) = 97.84, factor: trial × phase, p = 0.1764, F (2, 34) = 1.827). (E) In VGluT2-Cre mice, CNO injection 30 min before training significantly impaired freezing during the trace but not tone compared to vehicle group ( n = 10; two-way ANOVA with repeated measures; factor: treatment, p = 0.0132, F (1, 18) = 7.565, factor: phase, p < 0.0001, F (2, 36) = 41.47, factor: trial × phase, p = 0.0001, F (2, 36) = 12.00. (F) In VGluT1-Cre mice, terminal silencing with CNO did not affect freezing compared to vehicle controls ( n = 9; two-way ANOVA with repeated measures; factor: treatment, p = 0.0931, F (1, 16) = 3.189, factor: phase, p < 0.0001, F (2, 32) = 13.78, factor: trial × phase, p = 0.9968, F (2, 32) = 0.003253) when compared to vehicle controls. (H) Injections of CNO ( n = 10) before trace-light conditioning (TLC) training did not affect freezing during either the tone or light periods in mice expressing inhibitory DREADD only in VGluT2 + SUB→RSP projections ( n = 10; two-way ANOVA with repeated measures; factor: treatment, p = 0.2577, F (1, 18) = 1.366, factor: phase, p < 0.0001, F (2, 36) = 52.27, factor: trial × phase, p = 0.5714, F (2, 36) = 0.5685). (I) Injections of CNO before TLC training significantly impaired freezing to both tone and light when compared to vehicle in mice expressing inhibitory DREADD in all SUB→RSP projections compared to vehicle injected group ( n = 5–6; two-way ANOVA with repeated measures; factor: treatment, p = 0.0087, F (1, 9) = 11.12, factor: phase, p < 0.0001, F (2, 18) = 19.01, factor: trial × phase, p = 0.3846, F (2, 18) = 1.008. Data presented as mean ± SEM ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001; NS, not significant; WT, <t>wild-type.</t> All scale bars, 250 μm.
    Wild Type C57bl6 J Mice, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/wild+type+c57bl6+j+mice/bio_rxiv__64898__2026__03__19__712957-131-1-7?v=Charles+River+Laboratories
    Average 86 stars, based on 1 article reviews
    wild type c57bl6 j mice - by Bioz Stars, 2026-08
    86/100 stars
    		  Buy from Supplier
    female c57bl6 j wild type mice  (Charles River Laboratories)
    86
    Charles River Laboratories female c57bl6 j wild type mice
    VGluT2 + SUB→RSP afferents are specifically required for processing a temporal trace separating a cue and a shock (A, D, and G) Experimental design of behavioral tasks. Diagrams depict virus infusion sites in DH and cannula placements for CNO injections in RSP (top and right), and viral expression in RSP and DH (bottom and right). (B) When compared to vehicle, CNO injections 30 min before TFC training, impaired freezing at test in response to both the tone and trace periods in mice receiving AAV-hM4D (Gi) ( n = 9–10; two-way ANOVA with repeated measures; factor: treatment, p = 0.0098, F (1, 17) = 8.444, factor: phase, p < 0.0001, F (2, 34) = 67.41, factor: trial × phase, p = 0.0084, F (2, 34) = 5.522). (C) CNO injection before training in delay fear conditioning (DFC) did not affect freezing to tone or post-tone when compared to vehicle-injected mice ( n = 9–10; two-way ANOVA with repeated measures; factor: treatment, p = 0.6738, F (1, 17) = 0.1835, factor: phase, p < 0.0001, F (2, 34) = 97.84, factor: trial × phase, p = 0.1764, F (2, 34) = 1.827). (E) In VGluT2-Cre mice, CNO injection 30 min before training significantly impaired freezing during the trace but not tone compared to vehicle group ( n = 10; two-way ANOVA with repeated measures; factor: treatment, p = 0.0132, F (1, 18) = 7.565, factor: phase, p < 0.0001, F (2, 36) = 41.47, factor: trial × phase, p = 0.0001, F (2, 36) = 12.00. (F) In VGluT1-Cre mice, terminal silencing with CNO did not affect freezing compared to vehicle controls ( n = 9; two-way ANOVA with repeated measures; factor: treatment, p = 0.0931, F (1, 16) = 3.189, factor: phase, p < 0.0001, F (2, 32) = 13.78, factor: trial × phase, p = 0.9968, F (2, 32) = 0.003253) when compared to vehicle controls. (H) Injections of CNO ( n = 10) before trace-light conditioning (TLC) training did not affect freezing during either the tone or light periods in mice expressing inhibitory DREADD only in VGluT2 + SUB→RSP projections ( n = 10; two-way ANOVA with repeated measures; factor: treatment, p = 0.2577, F (1, 18) = 1.366, factor: phase, p < 0.0001, F (2, 36) = 52.27, factor: trial × phase, p = 0.5714, F (2, 36) = 0.5685). (I) Injections of CNO before TLC training significantly impaired freezing to both tone and light when compared to vehicle in mice expressing inhibitory DREADD in all SUB→RSP projections compared to vehicle injected group ( n = 5–6; two-way ANOVA with repeated measures; factor: treatment, p = 0.0087, F (1, 9) = 11.12, factor: phase, p < 0.0001, F (2, 18) = 19.01, factor: trial × phase, p = 0.3846, F (2, 18) = 1.008. Data presented as mean ± SEM ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001; NS, not significant; WT, <t>wild-type.</t> All scale bars, 250 μm.
    Female C57bl6 J Wild Type Mice, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/wild+type+c57bl6+j+mice/pm41680901-110-5-12?v=Charles+River+Laboratories
    Average 86 stars, based on 1 article reviews
    female c57bl6 j wild type mice - by Bioz Stars, 2026-08
    86/100 stars
    		  Buy from Supplier
    animals female c57bl6 j wild type mice  (Jackson Laboratory)
    86
    Jackson Laboratory animals female c57bl6 j wild type mice
    VGluT2 + SUB→RSP afferents are specifically required for processing a temporal trace separating a cue and a shock (A, D, and G) Experimental design of behavioral tasks. Diagrams depict virus infusion sites in DH and cannula placements for CNO injections in RSP (top and right), and viral expression in RSP and DH (bottom and right). (B) When compared to vehicle, CNO injections 30 min before TFC training, impaired freezing at test in response to both the tone and trace periods in mice receiving AAV-hM4D (Gi) ( n = 9–10; two-way ANOVA with repeated measures; factor: treatment, p = 0.0098, F (1, 17) = 8.444, factor: phase, p < 0.0001, F (2, 34) = 67.41, factor: trial × phase, p = 0.0084, F (2, 34) = 5.522). (C) CNO injection before training in delay fear conditioning (DFC) did not affect freezing to tone or post-tone when compared to vehicle-injected mice ( n = 9–10; two-way ANOVA with repeated measures; factor: treatment, p = 0.6738, F (1, 17) = 0.1835, factor: phase, p < 0.0001, F (2, 34) = 97.84, factor: trial × phase, p = 0.1764, F (2, 34) = 1.827). (E) In VGluT2-Cre mice, CNO injection 30 min before training significantly impaired freezing during the trace but not tone compared to vehicle group ( n = 10; two-way ANOVA with repeated measures; factor: treatment, p = 0.0132, F (1, 18) = 7.565, factor: phase, p < 0.0001, F (2, 36) = 41.47, factor: trial × phase, p = 0.0001, F (2, 36) = 12.00. (F) In VGluT1-Cre mice, terminal silencing with CNO did not affect freezing compared to vehicle controls ( n = 9; two-way ANOVA with repeated measures; factor: treatment, p = 0.0931, F (1, 16) = 3.189, factor: phase, p < 0.0001, F (2, 32) = 13.78, factor: trial × phase, p = 0.9968, F (2, 32) = 0.003253) when compared to vehicle controls. (H) Injections of CNO ( n = 10) before trace-light conditioning (TLC) training did not affect freezing during either the tone or light periods in mice expressing inhibitory DREADD only in VGluT2 + SUB→RSP projections ( n = 10; two-way ANOVA with repeated measures; factor: treatment, p = 0.2577, F (1, 18) = 1.366, factor: phase, p < 0.0001, F (2, 36) = 52.27, factor: trial × phase, p = 0.5714, F (2, 36) = 0.5685). (I) Injections of CNO before TLC training significantly impaired freezing to both tone and light when compared to vehicle in mice expressing inhibitory DREADD in all SUB→RSP projections compared to vehicle injected group ( n = 5–6; two-way ANOVA with repeated measures; factor: treatment, p = 0.0087, F (1, 9) = 11.12, factor: phase, p < 0.0001, F (2, 18) = 19.01, factor: trial × phase, p = 0.3846, F (2, 18) = 1.008. Data presented as mean ± SEM ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001; NS, not significant; WT, <t>wild-type.</t> All scale bars, 250 μm.
    Animals Female C57bl6 J Wild Type Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/wild+type+c57bl6+j+mice/pm41844581-206-0-16?v=Jackson+Laboratory
    Average 86 stars, based on 1 article reviews
    animals female c57bl6 j wild type mice - by Bioz Stars, 2026-08
    86/100 stars
    		  Buy from Supplier
    female c57bl6 j wild type mice  (Jackson Laboratory)
    86
    Jackson Laboratory female c57bl6 j wild type mice
    VGluT2 + SUB→RSP afferents are specifically required for processing a temporal trace separating a cue and a shock (A, D, and G) Experimental design of behavioral tasks. Diagrams depict virus infusion sites in DH and cannula placements for CNO injections in RSP (top and right), and viral expression in RSP and DH (bottom and right). (B) When compared to vehicle, CNO injections 30 min before TFC training, impaired freezing at test in response to both the tone and trace periods in mice receiving AAV-hM4D (Gi) ( n = 9–10; two-way ANOVA with repeated measures; factor: treatment, p = 0.0098, F (1, 17) = 8.444, factor: phase, p < 0.0001, F (2, 34) = 67.41, factor: trial × phase, p = 0.0084, F (2, 34) = 5.522). (C) CNO injection before training in delay fear conditioning (DFC) did not affect freezing to tone or post-tone when compared to vehicle-injected mice ( n = 9–10; two-way ANOVA with repeated measures; factor: treatment, p = 0.6738, F (1, 17) = 0.1835, factor: phase, p < 0.0001, F (2, 34) = 97.84, factor: trial × phase, p = 0.1764, F (2, 34) = 1.827). (E) In VGluT2-Cre mice, CNO injection 30 min before training significantly impaired freezing during the trace but not tone compared to vehicle group ( n = 10; two-way ANOVA with repeated measures; factor: treatment, p = 0.0132, F (1, 18) = 7.565, factor: phase, p < 0.0001, F (2, 36) = 41.47, factor: trial × phase, p = 0.0001, F (2, 36) = 12.00. (F) In VGluT1-Cre mice, terminal silencing with CNO did not affect freezing compared to vehicle controls ( n = 9; two-way ANOVA with repeated measures; factor: treatment, p = 0.0931, F (1, 16) = 3.189, factor: phase, p < 0.0001, F (2, 32) = 13.78, factor: trial × phase, p = 0.9968, F (2, 32) = 0.003253) when compared to vehicle controls. (H) Injections of CNO ( n = 10) before trace-light conditioning (TLC) training did not affect freezing during either the tone or light periods in mice expressing inhibitory DREADD only in VGluT2 + SUB→RSP projections ( n = 10; two-way ANOVA with repeated measures; factor: treatment, p = 0.2577, F (1, 18) = 1.366, factor: phase, p < 0.0001, F (2, 36) = 52.27, factor: trial × phase, p = 0.5714, F (2, 36) = 0.5685). (I) Injections of CNO before TLC training significantly impaired freezing to both tone and light when compared to vehicle in mice expressing inhibitory DREADD in all SUB→RSP projections compared to vehicle injected group ( n = 5–6; two-way ANOVA with repeated measures; factor: treatment, p = 0.0087, F (1, 9) = 11.12, factor: phase, p < 0.0001, F (2, 18) = 19.01, factor: trial × phase, p = 0.3846, F (2, 18) = 1.008. Data presented as mean ± SEM ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001; NS, not significant; WT, <t>wild-type.</t> All scale bars, 250 μm.
    Female C57bl6 J Wild Type Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/wild+type+c57bl6+j+mice/pmc12996317-266-0-17?v=Jackson+Laboratory
    Average 86 stars, based on 1 article reviews
    female c57bl6 j wild type mice - by Bioz Stars, 2026-08
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    VGluT2 + SUB→RSP afferents are specifically required for processing a temporal trace separating a cue and a shock (A, D, and G) Experimental design of behavioral tasks. Diagrams depict virus infusion sites in DH and cannula placements for CNO injections in RSP (top and right), and viral expression in RSP and DH (bottom and right). (B) When compared to vehicle, CNO injections 30 min before TFC training, impaired freezing at test in response to both the tone and trace periods in mice receiving AAV-hM4D (Gi) ( n = 9–10; two-way ANOVA with repeated measures; factor: treatment, p = 0.0098, F (1, 17) = 8.444, factor: phase, p < 0.0001, F (2, 34) = 67.41, factor: trial × phase, p = 0.0084, F (2, 34) = 5.522). (C) CNO injection before training in delay fear conditioning (DFC) did not affect freezing to tone or post-tone when compared to vehicle-injected mice ( n = 9–10; two-way ANOVA with repeated measures; factor: treatment, p = 0.6738, F (1, 17) = 0.1835, factor: phase, p < 0.0001, F (2, 34) = 97.84, factor: trial × phase, p = 0.1764, F (2, 34) = 1.827). (E) In VGluT2-Cre mice, CNO injection 30 min before training significantly impaired freezing during the trace but not tone compared to vehicle group ( n = 10; two-way ANOVA with repeated measures; factor: treatment, p = 0.0132, F (1, 18) = 7.565, factor: phase, p < 0.0001, F (2, 36) = 41.47, factor: trial × phase, p = 0.0001, F (2, 36) = 12.00. (F) In VGluT1-Cre mice, terminal silencing with CNO did not affect freezing compared to vehicle controls ( n = 9; two-way ANOVA with repeated measures; factor: treatment, p = 0.0931, F (1, 16) = 3.189, factor: phase, p < 0.0001, F (2, 32) = 13.78, factor: trial × phase, p = 0.9968, F (2, 32) = 0.003253) when compared to vehicle controls. (H) Injections of CNO ( n = 10) before trace-light conditioning (TLC) training did not affect freezing during either the tone or light periods in mice expressing inhibitory DREADD only in VGluT2 + SUB→RSP projections ( n = 10; two-way ANOVA with repeated measures; factor: treatment, p = 0.2577, F (1, 18) = 1.366, factor: phase, p < 0.0001, F (2, 36) = 52.27, factor: trial × phase, p = 0.5714, F (2, 36) = 0.5685). (I) Injections of CNO before TLC training significantly impaired freezing to both tone and light when compared to vehicle in mice expressing inhibitory DREADD in all SUB→RSP projections compared to vehicle injected group ( n = 5–6; two-way ANOVA with repeated measures; factor: treatment, p = 0.0087, F (1, 9) = 11.12, factor: phase, p < 0.0001, F (2, 18) = 19.01, factor: trial × phase, p = 0.3846, F (2, 18) = 1.008. Data presented as mean ± SEM ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001; NS, not significant; WT, wild-type. All scale bars, 250 μm.

    Journal: iScience

    Article Title: Response dynamics of discrete subiculum→retrosplenial cortex projections underlying trace fear conditioning

    doi: 10.1016/j.isci.2026.115317

    Figure Lengend Snippet: VGluT2 + SUB→RSP afferents are specifically required for processing a temporal trace separating a cue and a shock (A, D, and G) Experimental design of behavioral tasks. Diagrams depict virus infusion sites in DH and cannula placements for CNO injections in RSP (top and right), and viral expression in RSP and DH (bottom and right). (B) When compared to vehicle, CNO injections 30 min before TFC training, impaired freezing at test in response to both the tone and trace periods in mice receiving AAV-hM4D (Gi) ( n = 9–10; two-way ANOVA with repeated measures; factor: treatment, p = 0.0098, F (1, 17) = 8.444, factor: phase, p < 0.0001, F (2, 34) = 67.41, factor: trial × phase, p = 0.0084, F (2, 34) = 5.522). (C) CNO injection before training in delay fear conditioning (DFC) did not affect freezing to tone or post-tone when compared to vehicle-injected mice ( n = 9–10; two-way ANOVA with repeated measures; factor: treatment, p = 0.6738, F (1, 17) = 0.1835, factor: phase, p < 0.0001, F (2, 34) = 97.84, factor: trial × phase, p = 0.1764, F (2, 34) = 1.827). (E) In VGluT2-Cre mice, CNO injection 30 min before training significantly impaired freezing during the trace but not tone compared to vehicle group ( n = 10; two-way ANOVA with repeated measures; factor: treatment, p = 0.0132, F (1, 18) = 7.565, factor: phase, p < 0.0001, F (2, 36) = 41.47, factor: trial × phase, p = 0.0001, F (2, 36) = 12.00. (F) In VGluT1-Cre mice, terminal silencing with CNO did not affect freezing compared to vehicle controls ( n = 9; two-way ANOVA with repeated measures; factor: treatment, p = 0.0931, F (1, 16) = 3.189, factor: phase, p < 0.0001, F (2, 32) = 13.78, factor: trial × phase, p = 0.9968, F (2, 32) = 0.003253) when compared to vehicle controls. (H) Injections of CNO ( n = 10) before trace-light conditioning (TLC) training did not affect freezing during either the tone or light periods in mice expressing inhibitory DREADD only in VGluT2 + SUB→RSP projections ( n = 10; two-way ANOVA with repeated measures; factor: treatment, p = 0.2577, F (1, 18) = 1.366, factor: phase, p < 0.0001, F (2, 36) = 52.27, factor: trial × phase, p = 0.5714, F (2, 36) = 0.5685). (I) Injections of CNO before TLC training significantly impaired freezing to both tone and light when compared to vehicle in mice expressing inhibitory DREADD in all SUB→RSP projections compared to vehicle injected group ( n = 5–6; two-way ANOVA with repeated measures; factor: treatment, p = 0.0087, F (1, 9) = 11.12, factor: phase, p < 0.0001, F (2, 18) = 19.01, factor: trial × phase, p = 0.3846, F (2, 18) = 1.008. Data presented as mean ± SEM ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001; NS, not significant; WT, wild-type. All scale bars, 250 μm.

    Article Snippet: Wild type C57BL6/J mice were purchased from Harlan, Indianapolis, IN.

    Techniques: Virus, Expressing, Injection